(Q43662174)

English

Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

type-1 diabetes

1 reference

based on heuristic

inferred from title

author name string

N Chaturvedi

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J H Fuller

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F Pokras

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Rottiers

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

N Papazoglou

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

L P Aiello

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

EUCLID Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

288-294

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Platelet and coagulation factors in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2001.00441.X

21 January 2018

Identifiers

10.1046/J.1464-5491.2001.00441.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43662174&oldid=2131359873"